Study of Carboplatin Plus Etoposide With or Without SHR-1316 in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC)
Clinical trial NCT03711305 · UNKNOWN
Trial details
- NCT number
- NCT03711305
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-30
- Primary completion
- 2022-10-01
- Enrollment
- 462
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.